TFA
AMRX icon

Transamerica Financial Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Transamerica Financial Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Buy
10,019
+1,469
+17% +$20.1K 0.01% 453
2026
Q1 		$106K Buy
8,550
+5,636
+193% +$75.7K 0.01% 516
2025
Q4 		$36.7K Buy
2,914
+2,460
+542% +$28.1K ﹤0.01% 597
2025
Q3 		$4.54K Buy
+454
New +$4.08K ﹤0.01% 891

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Transamerica Financial Advisors's AMRX Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Amneal Pharmaceuticals (AMRX) stake by 17% in Q2 2026, buying an estimated $20.1K and bringing the position to 10,019 shares worth $173K. The position accounts for 0.01% of the portfolio, ranked #453.

Transamerica Financial Advisors first reported a position in AMRX in Q3 2025 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Transamerica Financial Advisors held 10,019 shares of Amneal Pharmaceuticals worth $173K as of Q2 2026.
  • Transamerica Financial Advisors bought 1,469 Amneal Pharmaceuticals shares in Q2 2026, an estimated $20.1K.
  • Amneal Pharmaceuticals made up 0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #453 holding.
  • Transamerica Financial Advisors first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.